We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




High BP Following Heart Surgery Linked to Adverse Outcomes

By HospiMedica International staff writers
Posted on 19 Sep 2016
Postoperative hypertension in cardiac surgery is associated with increased mortality, prolonged length of stay, and higher incidence of renal dysfunction, according to a new study.

Researchers at Charité University Medicine (Charité, Berlin, Germany), The Medicines Company (Parsippany, NJ, USA), and other institutions conducted a retrospective outcome analysis of 5,225 cardiac surgery patients treated at the University Hospital of Giessen and Marburg (UKGM; Germany) over a 7-year period, in order to evaluate the consequences of postoperative blood pressure (BP) on medical outcomes and resource utilization.

The results revealed that hypertensive postoperative patients experienced a higher in-hospital mortality rate (4.97%) compared with matched-case normotensive patients (1.32%) and a longer hospital stay. More...
In addition, serum creatinine levels in the hypertensive patients were increased (25.3%), and postoperative renal dysfunction occurred significantly more often (19.7%) than in normotensive patients. The study was published on September 9, 2016, in the Journal of Cardiothoracic and Vascular Anesthesia.

“The results of this study, showing a relationship between high postoperative BP with acute kidney injury and mortality, were confined to high-risk patients who underwent cardiac surgery,” concluded senior author Prosser Michael Sander, MD, of UKGM, and colleagues. “To what extent, if any, these results applied to patients with similar demographics who undergo non-cardiac surgery or even to different patient cohorts remain speculative.”

Acute kidney injury (AKI) after cardiac surgery has an incidence rate of 2-8% and confers significant morbidity, increased resource utilization, and greater short- and long-term mortality. Known risk factors for AKI after cardiac surgery are expansive, and include both poorly controlled preoperative and intra-operative BP. The specific contribution of post- operative BP and BP management on the development or progression of AKI and outcomes is less well understood.

Related Links:
Charité University Medicine
The Medicines Company
University Hospital of Giessen and Marburg



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.